GA-LDV: A Promising Derivative of 18β-Glycyrrhetinic Acid with Enhanced in vitro and in vivo Anti-Cancer Properties

GA-LDV: A Promising Derivative of 18β-Glycyrrhetinic Acid with Enhanced in vitro and in vivo Anti-Cancer Properties

Jiaying Zheng,1,* Qiqi Feng,1,* Qi Gao,1 Yaonan Wang,1 Shurui Zhao,1 Xiaoyi Zhang,1 Ming Zhao1,2 1Beijing Area Major Laboratory of Peptide and Small Molecular Drugs, Department of Medicinal Chemistry, School of Pharmaceutical Sciences, Capital Medical University, Beijing, 100069, Peo...

Full description

Saved in:
Bibliographic Details
Main Authors: Zheng J, Feng Q, Gao Q, Wang Y, Zhao S, Zhang X, Zhao M
Format: Article
Language:English
Published: Dove Medical Press 2025-04-01
Series:Drug Design, Development and Therapy
Subjects:
18β-glycyrrhetinic acid
anti-tumor
anti-metastasis activity
lung cancer
mmp
Online Access:https://www.dovepress.com/ga-ldv-a-promising-derivative-of-18-glycyrrhetinic-acid-with-enhanced--peer-reviewed-fulltext-article-DDDT
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.dovepress.com/ga-ldv-a-promising-derivative-of-18-glycyrrhetinic-acid-with-enhanced--peer-reviewed-fulltext-article-DDDT

Similar Items